Reconciliation disputes are usually what delay pharma payments, so the notice should attach a clear ledger and separate undisputed dues from disputed credit notes. MSME units supplying marketing companies use Samadhaan; distributors with cheque dues use Section 138; agreements often have arbitration clauses.
Pharmaceuticals and pharma distribution in Thiruvananthapuram
The state capital’s suppliers largely serve government departments, hospitals, Technopark companies and the hospitality sector. Government dues delay through sanction and audit rather than dispute; MSME Samadhaan applies to them, and Kerala’s Council is accessible from the capital.
Manufacturers sell to marketing companies on 45 to 90 day credit; stockists and distributors carry brand dues against schemes, expiry returns and credit notes that are reconciled slowly.
Proof to collect
Typically purchase orders, batch-wise invoices, GRNs or stockist acknowledgements, scheme and credit-note records, and the distribution agreement.
- Avoid: unsigned credit notes and scheme adjustments
- Avoid: expiry and breakage returns with no agreed policy
- Avoid: loan-licence work without a written manufacturing agreement
- Avoid: distribution agreements with an arbitration clause nobody read
Forums in Thiruvananthapuram
| Route | Forum |
|---|---|
| Section 138 (cheque bounce) | Judicial First Class Magistrate courts, Thiruvananthapuram, for Section 138 |
| Summary suit / recovery suit | District Court, Thiruvananthapuram, and its Commercial Court for recovery suits. |
| MSME Samadhaan | Kerala Micro and Small Enterprises Facilitation Council (detail) |
| Arbitration | As per the contract clause |
How FundRaksha works for pharmaceuticals and pharma distribution suppliers in Thiruvananthapuram
- Free assessment of the documents your trade produces.
- Notice within 24 hours, itemising invoices, disputed and undisputed amounts and interest.
- Negotiation and documented settlement.
- Filing in Thiruvananthapuram or before the Council if needed.
30% on recovery, nothing upfront.